First American Trust’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-19,108
Closed -$3.92M 128
2017
Q3
$3.92M Buy
19,108
+468
+3% +$109K 1.02% 37
2017
Q2
$4.53M Buy
18,640
+1,559
+9% +$366K 1.26% 28
2017
Q1
$4.08M Buy
+17,081
New +$3.98M 1.24% 32
2016
Q2
Sell
-860
Closed -$231K 108
2016
Q1
$231K Buy
860
+205
+31% +$58.7K 0.08% 95
2015
Q4
$205K Sell
655
-165
-20% -$49.1K 0.08% 92
2015
Q3
$223K Hold
820
0.09% 85
2015
Q2
$249K Hold
820
0.09% 85
2015
Q1
$244K Hold
820
0.09% 82
2014
Q4
$211K Buy
+820
New +$205K 0.08% 88

Other funds holding AGN

First American Trust's AGN Position: Q4 2017 in Review

First American Trust sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 19,108 shares — an estimated $3.92M sold.

First American Trust first reported a position in AGN in Q4 2014 and held it in 9 quarters. The position peaked at $4.53M in Q2 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • First American Trust reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • First American Trust sold 19,108 Allergan plc shares in Q4 2017, an estimated $3.92M.
  • First American Trust first reported a position in Allergan plc in Q4 2014 and held it in 9 quarters.
  • First American Trust's Allergan plc position peaked at $4.53M in Q2 2017.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on First American Trust's 13F filing for Q4 2017, filed 11 Jan 2018.